Patent details

Basic Information

Publication number:

EP3496752

PCT Application Number:

US2017046458

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP177576295

PCT Publication Number:

WO2018031865

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATION THERAPY WITH A MEK INHIBITOR, A PD-1 AXIS INHIBITOR, AND A VEGF INHIBITOR

French Title of Invention:

POLYTHÉRAPIE AVEC UN INHIBITEUR DE MEK, UN INHIBITEUR DE L'AXE PD-1 ET UN INHIBITEUR DE VEGF

German Title of Invention:

KOMBINATIONSTHERAPIE MIT EINEM MEK-INHIBITOR, EINEM PD-1-ACHSEN-INHIBITOR UND EINEM VEGF-INHIBITOR

SPC Number:

Dates

Filing date:

11/08/2017

Grant date:

18/05/2022

EP Publication Date:

19/06/2019

PCT Publication Date:

15/02/2018

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

18/05/2022

EP B1 Publication Date:

18/05/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

11/08/2022

Expiration date:

11/08/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/05/2022

 

 

Name:

Genentech, Inc.

Address:

1 DNA Way, South San Francisco, CA 94080, United States (US)

Inventor

Name:

CHOONG, Nicholas

Address:

United States (US)

Priority

Priority Number:

201662374437 P

Priority Date:

12/08/2016

Priority Country:

United States (US)

Classification

IPC classification:

A61K 39/395; A61K 31/00; C07K 16/22; C07K 16/28;

Publication

European Patent Bulletin

Issue number:

202220

Publication date:

18/05/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages